Current Methods of Measuring Intracranial Pressure are Invasive, Expensive, and Risky. The current method for measuring intracranial pressure involves drilling a hole in the skull and physically inserting a sensor into the brain.

Because this procedure is invasive and introduces additional risk factors, it is only used for patients in critical condition, typically in a coma. In 98% of traumatic brain injuries, the intracranial pressure is never tested. This leaves patients vulnerable to brain damage, seizure, coma, stroke, or even death.

CranioSense has developed IPASS, a technology that measures intracranial pressure in seconds, without the need to drill a hole in the skull or insert a sensor into the brain. IPASS measures intracranial pressure (ICP) with an easy-to-use system that only requires a patch on the forehead, two clip-on sensors, and a handheld device the size of an iPad.

In this episode, we discuss how Ryan Myers of CranioSense is discovering what their beachhead market should be, how to build the right team, and navigate between grant and venture funding to co-develop a winning medical product.